Ex-GSK China researchers hit back
This article was originally published in Scrip
The Chinese GlaxoSmithKline scientist who resigned in relation to alleged "misrepresentation of data" in a leading science journal has claimed not only that the data were authentic and reproducible but has also suggested that the internal investigation by the pharma firm may have been unbalanced.
You may also be interested in...
Under Momenta/CSL autoimmune partnership, Momenta can opt in to co-development or commercialization on recombinant Fc receptor modulator or just earn a revenue stream from CSL’s efforts with the preclinical candidate. Pieris and Servier sign broad-based immuno-oncology collaboration, while Arena hands off the disappointing Belviq to Eisai.
Despite the urgency to have many more notified bodies designated under the MDR and IVDR, COVID-19 fall-out has resulted in a hiatus in their appointment, Commission figures show.
Reckitt hires chief digital officer from Nestlé and shakes up Australia leadership; GSCF names Bayer's Schipper as chair; and Europe's CMDh appoints a new chair.